LERCANIDIPINE, CALCIUM CHANNEL BLOCKER OF THE THIRD GENERATION: NEW POSSIBILITIES IN THE TREATMENT OF ARTERIAL HYPERTENSION

Classification, modes of action and clinical effects of calcium channel blockers are presented. Advantages of the third generation of dihydropyridine calcium channel blockers are considered. Clinical pharmacology, studies on the efficacy, safety and prevention of hypertensive complications with lerc...

Full description

Saved in:
Bibliographic Details
Main Authors: O. D. Ostroumova (Author), M. L. Maksimov (Author), I. I. Kopchenov (Author)
Format: Book
Published: Столичная издательская компания, 2015-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_c36845fac9ee4c8881cc50a6a0c6baf6
042 |a dc 
100 1 0 |a O. D. Ostroumova  |e author 
700 1 0 |a M. L. Maksimov  |e author 
700 1 0 |a I. I. Kopchenov  |e author 
245 0 0 |a LERCANIDIPINE, CALCIUM CHANNEL BLOCKER OF THE THIRD GENERATION: NEW POSSIBILITIES IN THE TREATMENT OF ARTERIAL HYPERTENSION 
260 |b Столичная издательская компания,   |c 2015-09-01T00:00:00Z. 
500 |a 1819-6446 
500 |a 2225-3653 
500 |a 10.20996/1819-6446-2013-9-1-79-85 
520 |a Classification, modes of action and clinical effects of calcium channel blockers are presented. Advantages of the third generation of dihydropyridine calcium channel blockers are considered. Clinical pharmacology, studies on the efficacy, safety and prevention of hypertensive complications with lercanidipine are detailed. 
546 |a EN 
546 |a RU 
690 |a arterial hypertension 
690 |a antihypertensive therapy 
690 |a calcium antagonists 
690 |a lercanidipine 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
690 |a Diseases of the circulatory (Cardiovascular) system 
690 |a RC666-701 
655 7 |a article  |2 local 
786 0 |n Рациональная фармакотерапия в кардиологии, Vol 9, Iss 1, Pp 79-85 (2015) 
787 0 |n https://www.rpcardio.online/jour/article/view/77 
787 0 |n https://doaj.org/toc/1819-6446 
787 0 |n https://doaj.org/toc/2225-3653 
856 4 1 |u https://doaj.org/article/c36845fac9ee4c8881cc50a6a0c6baf6  |z Connect to this object online.